Occult breast cancer may originate from ectopic breast tissue present in axillary lymph nodes Mitsuo TeradaYayoi AdachiHiroji Iwata Review 20 July 2018 Pages: 1 - 7
CDK4/6 inhibitors in advanced hormone receptor-positive/HER2-negative breast cancer: a systematic review and meta-analysis of randomized trials Carlo MessinaCarlo CattriniFrancesco Boccardo Review 27 July 2018 Pages: 9 - 21
PARP3 inhibitors ME0328 and olaparib potentiate vinorelbine sensitization in breast cancer cell lines Bahram Sharif-AskariLilian AmreinLawrence Panasci Preclinical study 23 July 2018 Pages: 23 - 32
Field template-based design and biological evaluation of new sphingosine kinase 1 inhibitors Heba AlshakerShyam SrivatsDmitri Pchejetski Preclinical study Open access 24 July 2018 Pages: 33 - 43
Oestrogen receptor-regulated glutathione S-transferase mu 3 expression attenuates hydrogen peroxide-induced cytotoxicity, which confers tamoxifen resistance on breast cancer cells Juo-Han LinShih-Hsin TuYuan-Soon Ho Preclinical study 27 July 2018 Pages: 45 - 59
Clinicopathological and prognostic significance of Ras association and pleckstrin homology domains 1 (RAPH1) in breast cancer Sasagu KurozumiChitra JosephEmad A. Rakha Preclinical study 28 July 2018 Pages: 61 - 68
Combination of anthracyclines and anti-CD47 therapy inhibit invasive breast cancer growth while preventing cardiac toxicity by regulation of autophagy Yismeilin R. Feliz-MosqueaAshley A. ChristensenDavid R. Soto-Pantoja Preclinical study 28 July 2018 Pages: 69 - 82
Perometry versus simulated circumferential tape measurement for the detection of breast cancer-related lymphedema Fangdi SunAlexander HallAlphonse G. Taghian Preclinical study 30 July 2018 Pages: 83 - 91
The clinical relevance of serum vascular endothelial growth factor (VEGF) in correlation to circulating tumor cells and other serum biomarkers in patients with metastatic breast cancer Malgorzata Banys-PaluchowskiIsabell WitzelVolkmar Müller Clinical trial 12 July 2018 Pages: 93 - 104
Randomized controlled trial of weight loss versus usual care on telomere length in women with breast cancer: the lifestyle, exercise, and nutrition (LEAN) study Tara SanftIlana UsiskinMelinda L. Irwin Clinical trial 30 July 2018 Pages: 105 - 112
Clinical subtypes and prognosis of pregnancy-associated breast cancer: results from the Korean Breast Cancer Society Registry database Soo Youn BaeSei Joong KimSeung Pil Jung Clinical trial 07 August 2018 Pages: 113 - 121
Intra-tumor molecular heterogeneity in breast cancer: definitions of measures and association with distant recurrence-free survival Ashirbani SahaMichael R. HarowiczMaciej A. Mazurowski Epidemiology 10 July 2018 Pages: 123 - 132
Screening status, tumour subtype, and breast cancer survival: a national population-based analysis Katie M. O’BrienTherese MooneyLinda Sharp Epidemiology 13 July 2018 Pages: 133 - 142
Cost-effectiveness of monitoring endoxifen levels in breast cancer patients adjuvantly treated with tamoxifen M. van NulandR. A. VremanA. M. Hövels Epidemiology Open access 13 July 2018 Pages: 143 - 150
The yield of full BRCA1/2 genotyping in Israeli high-risk breast/ovarian cancer patients who do not carry the predominant mutations Inbal Barnes-KedarRinat Bernstein-MolhoYael Goldberg Epidemiology 16 July 2018 Pages: 151 - 157
Sexual health in long-term breast cancer survivors Sara V. SolderaMarguerite EnnisPamela J. Goodwin Epidemiology 19 July 2018 Pages: 159 - 166
Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidity W. WulaningsihH. GarmoM. Lambe Epidemiology Open access 21 July 2018 Pages: 167 - 177
De novo vitamin D supplement use post-diagnosis is associated with breast cancer survival J. M. MaddenL. MurphyK. Bennett Epidemiology 23 July 2018 Pages: 179 - 190
Molecular subtypes of screen-detected breast cancer Gelareh FarshidDavid Walters Epidemiology 25 July 2018 Pages: 191 - 199
Impact of race, ethnicity, and socioeconomic factors on receipt of radiation after breast conservation surgery: analysis of the national cancer database Arti ParekhWei FuJean L. Wright Epidemiology 06 August 2018 Pages: 201 - 208
Pro-inflammatory cytokines and growth factors in human milk: an exploratory analysis of racial differences to inform breast cancer etiology Jeanne MurphyRuth M. PfeifferMark E. Sherman Epidemiology 06 August 2018 Pages: 209 - 219
Onco-metabolism: defining the prognostic significance of obesity and diabetes in women with brain metastases from breast cancer Neal S. McCallBrittany A. SimoneNicole L. Simone Brief Report 18 July 2018 Pages: 221 - 230
Population-based validation of the National Cancer Comprehensive Network recommendations for breast cancer staging Omar Abdel-Rahman Brief Report 18 July 2018 Pages: 231 - 238
Towards treatment personalisation in triple negative breast cancer: role of platinum-based neoadjuvant chemotherapy Mattia ReditiCarlo Messina Letter to the Editor 12 July 2018 Pages: 239 - 240
Heterogeneity of tumor cells and metastases in breast cancer patients: cause or consequence? Darko ZdravkovicDejan NikolicMarija Zdravkovic Letter to the Editor 04 August 2018 Pages: 241 - 241
Glucocorticoids in breast cancer treatment: real benefit or selection bias? Gurkan GunerOmer Dizdar Letter to the Editor 26 July 2018 Pages: 243 - 243
Rebuttal comments on “Glucocorticoids in breast cancer treatment: Real benefit or selection bias?” Ching-Hung LinChao-Hsiun Tang Rebuttal Letter 02 August 2018 Pages: 245 - 245
